Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer

计划入组 51 人 · 首次发布于 2007 年 12 月 28 日

Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer

计划入组 42 人 · 首次发布于 2014 年 6 月 5 日

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

计划入组 33 人 · 首次发布于 2022 年 7 月 13 日

Carotuximab

4SCAR-CD10

89Zr-anti-CD103 tracer

Kairos Pharma Reports Zero Grade 3+ Toxicities in Phase 1 Trial of ENV-105 for EGFR-Mutated Lung Cancer

Kairos Pharma Advances Oncology Therapeutics with ENV105 in Clinical Trials

Kairos Pharma Expands ENV105 Trial with City of Hope and Huntsman Cancer Institute